Kobayashi Pharmaceutical net profit surges 120% despite sales decline

Kobayashi Pharmaceutical reported interim net profit surged 120.5% to 3,167 million yen despite net sales falling 5.6% to 69,018 million yen for the fiscal year ending December 2025.

Operating profit dropped 29.8% to 6,648 million yen. The company incurred 2,912 million yen in product recall-related special losses.

Domestic healthcare and daily necessities sales recovered through new products and price increases, while international sales declined.